Where does 3NT Medical Ltd. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), 3NT Medical Ltd. ranks #23,742 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does 3NT Medical Ltd. hold?

3NT Medical Ltd. holds 11 US utility patents granted between 2019 and 2025, spanning 3 technology areas.

What is 3NT Medical Ltd.'s Innovation Score?

3NT Medical Ltd. has an Innovation Score of 29.9 out of 100 (32nd percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does 3NT Medical Ltd. focus on?

3NT Medical Ltd.'s top technology area is A61B (DIAGNOSIS; SURGERY; Identification) with 11 patents, ranking #1,592 of 7,127 assignees active in that subclass. Grants appear in 3 CPC subclasses total.

Is 3NT Medical Ltd.'s patent grant rate increasing or decreasing?

3NT Medical Ltd.'s recent grant velocity is +300% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for 3NT Medical Ltd.'s patents?

3NT Medical Ltd.'s patents average 14.3 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the 3NT Medical Ltd. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

3NT Medical Ltd.

USPTO PatentsView assignee record - 11 granted patents across 3 technology areas, recorded in grant years 2019–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, 3NT ranks #23,742 of 49,997 tracked US assignees by granted-patent volume, with 11 patents across 3 technology areas.

#23,742
of 49,997 US assignees by volume: 32nd percentile
by Innovation Score (29.9/100): 14.3
avg claims per patent: +300%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R23742 · Foreign Corporation #23,742 · 11 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 11 grants
MID-PACK #23,742/49,997
PHOTO-FINISH 20/20 Vision Center
CPC-NARROW A61B · 3 areas
INNOV-THIN 29.9/100
CLAIMS-RICH 14.3 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-SURGE +300% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: 20/20 Vision Center, LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How 3NT’s 29.9 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 8.6 pts (29%) Velocity 6.7 pts (22%) Breadth 6.1 pts (20%) Claim depth 8.6 pts (29%)

Qualcomm Incorporated · highest

85
3NT Medical · this assignee

30
3D Lighting… · lowest

7

What this shows 3NT's Innovation Score is 29.9/100 (32nd percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for 3NT?

Each dot is one of 3NT’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). 3NT’s own 14.3 claims/patent is at or below the 14.6 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

3NT vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where 3NT's grants concentrate

3NT Medical Ltd. is a focused PatentsView assignee: 3 CPC subclasses with 100% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2021 (3 grants) versus a trough of 1 in 2022. By volume, 3NT sits between 20/20 Vision Center, LLC and 4SC AG.

3NT's three-year grant acceleration

3NT Medical Ltd. shows 5 grants in 2022–2024 against only 5 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

20/20 Vision Cent…

11
2J Antennas USA

11
3-east

11
3D at Depth

11
4361423 Canada

11
4iiii Innovations

11
4knines

11
4SC

11
3NT Medical ◀

11

What this shows 3NT holds 11 patents at rank #23,742, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near 3NT

By rank, the assignees closest to #23,742 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in 3NT's primary technology class.

3NT's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

30 32nd percentile higher than 32% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2019–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2019–2019 baseline. Full figures in the table below.

View data table

3NT Medical Ltd. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2019	2	18.2%
2021	3	27.3%
2022	1	9.1%
2023	1	9.1%
2024	3	27.3%
2025partial year	1	9.1%

Which technologies does 3NT Medical Ltd. patent most?

A61B - DIAGNOSIS; SURGERY; Identification 11

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 9

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 6

Top 3 of 3 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

3NT Medical Ltd.'s patent record in context - here's where to go next.

3NT Medical Ltd.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 100% of its portfolio - see every assignee active in that class. Explore A61B
Ranked #23,742 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare 3NT Medical Ltd. against 20/20 Vision Center, LLC, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 29.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.